{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:57:22Z","timestamp":1792807042116,"version":"4.5.0"},"reference-count":27,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006506","name":"Brazilian Society of Rheumatology","doi-asserted-by":"publisher","award":["SBR2021SAFER001"],"award-info":[{"award-number":["SBR2021SAFER001"]}],"id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Minist\u00e9rio da Sa\u00fade do Brasil, MS, Departamento de Ci\u00eancia e Tecnologia (DECIT)","award":["SBR2021SAFER001"],"award-info":[{"award-number":["SBR2021SAFER001"]}],"id":[{"id":"https:\/\/ror.org\/04p280284","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: The effectiveness of COVID-19 vaccine in patients with immune-mediated inflammatory diseases (IMID) depends on the underlying disease, immunosuppression degree and the vaccine regimens. We evaluate the safety and immunogenicity of different COVID-19 vaccine schedules. Methods: The SAFER study: \u201cSafety and effectiveness of the COVID-19 Vaccine in Rheumatic Disease\u201d, is a Brazilian multicentric prospective observational phase IV study in the real-life. Data were analyzed after 2 or 3 doses of COVID-19 vaccines: adenoviral vectored vaccine (ChAdOx1 nCoV-19, Astrazeneca), mRNA vaccine (BNT162b2, Pfizer\u2013BioNTech) or inactivated SARS-COV-2 vaccine (CoronaVac, Sinovac Biotech). IgG antibody against SARS-CoV-2 spike (IgG-S) receptor-binding domain level were quantified at baseline (T1) and 28 days after the first (T2), 2nd (T3) and 3rd (T4) doses by chemiluminescence (SARS-CoV-2-IgG-II Quant-assay, Abbott-Laboratories). Results: 721 patients with IMID were included in the analysis. The median titers of IgG-S (BAU\/mL) increased progressively over the times: at baseline was 6.26 (5.41\u20137.24), T2: 73.01 (61.53\u201386.62), T3: 200.0 (174.36\u2013229.41) and T4: 904.92 (800.49\u20131022.97). The multivariate linear regression showed that greater IgG-S titers were associated with pre-exposure to COVID-19 (p &lt; 0.001) and BNT162b2 booster vaccine (p &lt; 0.001). Rituximab and immunosuppressant drugs were independent factors for low titers (p = 0.002, p &lt; 0.001, respectively). No serious adverse event was reported. Conclusions: All platforms were safe and induced an increase in IgG-S antibodies. COVID-19 pre-exposure and BNT162b2 booster regimens were predictors of higher humoral immune responses, which is relevant in immunosuppressed populations. Immunosuppressants (mainly rituximab) predicted the lowest antibodies.<\/jats:p>","DOI":"10.3390\/vaccines12121367","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T04:01:29Z","timestamp":1733198489000},"page":"1367","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2545-6795","authenticated-orcid":false,"given":"Ketty Lysie Libardi Lira","family":"Machado","sequence":"first","affiliation":[{"name":"Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes da Universidade Federal do Esp\u00edrito Santo (HUCAM-UFES\/EBSERH), Vit\u00f3ria 29041-295, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5056-5523","authenticated-orcid":false,"given":"Ana Paula Neves","family":"Burian","sequence":"additional","affiliation":[{"name":"Centro de Refer\u00eancias para Imunobiol\u00f3gicos Especiais (CRIE) da Secretaria de Sa\u00fade do Estado do Esp\u00edrito Santo, Vit\u00f3ria 29047-105, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-4889","authenticated-orcid":false,"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[{"name":"Grupo Integrado de Pesquisas em Biomarcadores, Instituto Ren\u00e9 Rachou, Funda\u00e7\u00e3o Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-368X","authenticated-orcid":false,"given":"Jos\u00e9 Geraldo","family":"Mill","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes da Universidade Federal do Esp\u00edrito Santo (HUCAM-UFES\/EBSERH), Vit\u00f3ria 29041-295, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunara Baptista","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes da Universidade Federal do Esp\u00edrito Santo (HUCAM-UFES\/EBSERH), Vit\u00f3ria 29041-295, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Rosemarie Lallemand","family":"Tapia","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes da Universidade Federal do Esp\u00edrito Santo (HUCAM-UFES\/EBSERH), Vit\u00f3ria 29041-295, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina Sim\u00f5es","family":"Moulin","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes da Universidade Federal do Esp\u00edrito Santo (HUCAM-UFES\/EBSERH), Vit\u00f3ria 29041-295, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-9581","authenticated-orcid":false,"given":"Isac Ribeiro","family":"Moulaz","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes da Universidade Federal do Esp\u00edrito Santo (HUCAM-UFES\/EBSERH), Vit\u00f3ria 29041-295, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Dias Cardoso","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa de Oliveira","family":"Magalh\u00e3es","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-040X","authenticated-orcid":false,"given":"Erika","family":"Biegelmeyer","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Maria Matos Melo Campos","family":"Peixoto","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L\u00facia Euz\u00e9bio","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Escola de Medicina, Universidade Federal do Amazonas (UFAM), Manaus 69067-005, AM, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Maria Paiva Fran\u00e7a","family":"Telles","sequence":"additional","affiliation":[{"name":"Escola de Medicina, Universidade Federal do Amazonas (UFAM), Manaus 69067-005, AM, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"B\u00fchring","sequence":"additional","affiliation":[{"name":"Escola de Medicina, Universidade Federal do Amazonas (UFAM), Manaus 69067-005, AM, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-0771","authenticated-orcid":false,"given":"Natalia Sarzi","family":"Sartorio","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90010-150, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Hax","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90010-150, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Poubel Vieira de","family":"Rezende","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense, Rheumatology, Niteroi 24020-140, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6134-8495","authenticated-orcid":false,"given":"Katia Lino","family":"Baptista","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense, Rheumatology, Niteroi 24020-140, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-9965","authenticated-orcid":false,"given":"Ana Karla Guedes de","family":"Melo","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Lauro Wanderley, Universidade Federal da Para\u00edba (UFPB), Jo\u00e3o Pessoa 58051-900, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Alves","family":"Cruz","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina, Universidade Federal de Goi\u00e1s (UFG), Goi\u00e2nia 74690-900, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-6064","authenticated-orcid":false,"given":"Rejane Maria Rodrigues de Abreu","family":"Vieira","sequence":"additional","affiliation":[{"name":"Hospital Geral de Fortaleza (HGF), Universidade de Fortaleza (UNIFOR), Fortaleza 60150-160, CE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Henriques de","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora 36036-900, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-388X","authenticated-orcid":false,"given":"Valderilio Feij\u00f3","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Edumed Educa\u00e7\u00e3o em Sa\u00fade, Rheumatology, Curitiba 80440-210, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo de Medeiros","family":"Pinheiro","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odirlei Andr\u00e9","family":"Monticielo","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90010-150, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgard Torres Dos","family":"Reis Neto","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[{"name":"Grupo Integrado de Pesquisas em Biomarcadores, Instituto Ren\u00e9 Rachou, Funda\u00e7\u00e3o Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-4533","authenticated-orcid":false,"given":"Ricardo Machado","family":"Xavier","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90010-150, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-014X","authenticated-orcid":false,"given":"Emilia Inoue","family":"Sato","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-3776","authenticated-orcid":false,"given":"Viviane Angelina","family":"de Souza","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora 36036-900, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda Aparecida","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Locomotor System Department, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0054-7754","authenticated-orcid":false,"given":"Gecilmara Salviato","family":"Pileggi","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina (EPM), Universidade Federal de S\u00e3o Paulo (UNIFESP), S\u00e3o Paulo 04023-062, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Valim","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Cassiano Ant\u00f4nio Moraes da Universidade Federal do Esp\u00edrito Santo (HUCAM-UFES\/EBSERH), Vit\u00f3ria 29041-295, ES, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024, July 02). 2023 data.who.int, WHO Coronavirus (COVID-19) Dashboard > Deaths [Dashboard]. Available online: https:\/\/data.who.int\/dashboards\/covid19\/deaths."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s42358-022-00234-7","article-title":"Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: A Brazilian Society of Rheumatology task force","volume":"62","author":"Tavares","year":"2022","journal-title":"Adv. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Widhani, A., Hasibuan, A.S., Rismawati, R., Maria, S., Koesnoe, S., Hermanadi, M.I., Ophinni, Y., Yamada, C., Harimurti, K., and Sari, A.N.L. (2023). Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Vaccines, 11.","DOI":"10.3390\/vaccines11091456"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Szebeni, G.J., G\u00e9mes, N., Honfi, D., Szab\u00f3, E., Neuperger, P., Balog, J.\u00c1., Nagy, L.I., Szekanecz, Z., Pusk\u00e1s, L.G., and Toldi, G. (2022). Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.846248"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2021-221244","article-title":"Impact of Disease-Modifying Antirheumatic Drugs on Vaccine Immunogenicity in Patients With Inflammatory Rheumatic and Musculoskeletal Diseases","volume":"80","author":"Friedman","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1002\/art.42109","article-title":"American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4","volume":"74","author":"Curtis","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/annrheumdis-2021-220272","article-title":"Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort","volume":"80","author":"Geisen","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: A multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e001898","DOI":"10.1136\/rmdopen-2021-001898","article-title":"Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases","volume":"8","year":"2022","journal-title":"RMD Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","article-title":"Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: A phase 4 trial","volume":"27","author":"Aikawa","year":"2021","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00296-021-04917-0","article-title":"Safety of the ChAdOx1 nCoV-19 Ncov-19 and the BBV152 Vaccines in 724 Patients With Rheumatic Diseases: A Post-Vaccination Cross-Sectional Survey","volume":"41","author":"Cherian","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42358-019-0056-x","article-title":"Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases","volume":"59","author":"Pileggi","year":"2019","journal-title":"Adv. Rheumatol."},{"key":"ref_13","unstructured":"Valim, V., Machado, K.L.L.L., Miyamoto, S.T., Pinto, A.D., Rocha, P.C.M., Serrano, E.V., Dinis, V.G., Gouv\u00eaa, S.A., Dias, J.G.F., and Campi-Azevedo, A.C. (2020). Planned yellow fever Primovaccination is Safe and immunogenic in patients with autoimmune diseases: A prospective non-interventional study. Front. Immunol., 11."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","article-title":"Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac-PROFISCOV: A structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Palacios","year":"2020","journal-title":"Trials"},{"key":"ref_15","first-page":"365","article-title":"Evaluation of the Moderna, Pfizer\/Biotech, Astrazeneca\/Oxford and Sputnik V Vaccines for Covid-19","volume":"7","year":"2020","journal-title":"Adv. Res. J. Med. Clin. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_17","unstructured":"(2022, April 18). Causality Assessment of an Adverse Event Following Immunization (AEFI): USER Manual for the Revised WHO Classification. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/80670."},{"key":"ref_18","first-page":"2016","article-title":"Minimal disease activity for rheumatoid arthritis: A preliminary definition","volume":"32","author":"Wells","year":"2005","journal-title":"J. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e0197321","DOI":"10.1128\/jvi.01973-21","article-title":"Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters","volume":"96","author":"Burckhardt","year":"2022","journal-title":"J. Virol."},{"key":"ref_20","first-page":"1269","article-title":"Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study","volume":"83","author":"Calderaro","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijid.2022.10.035","article-title":"Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study","volume":"125","author":"Farroni","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/annrheumdis-2021-221824","article-title":"BNT162b2 mRNA COVID-19 Vaccine and Booster in Patients With Autoimmune Rheumatic Diseases: A National Cohort Study","volume":"81","author":"Bieber","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.15585\/mmwr.mm7112e1","article-title":"Effectiveness of mRNA vaccination in preventing COVID-19-associated invasive mechanical ventilation and death\u2014United States, March 2021\u2013January 2022","volume":"71","author":"Ferdinands","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.7326\/M21-1757","article-title":"Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: A prospective cohort study","volume":"174","author":"Deepak","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102927","DOI":"10.1016\/j.autrev.2021.102927","article-title":"Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis","volume":"21","author":"Jena","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1016\/j.vaccine.2023.08.022","article-title":"Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose","volume":"41","author":"Moulaz","year":"2023","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00296-021-05017-9","article-title":"Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: A cross-sectional study","volume":"41","year":"2021","journal-title":"Rheumatol. Int."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/12\/1367\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:45:36Z","timestamp":1760114736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/12\/1367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["vaccines12121367"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12121367","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}